IL22 and Hepatic fibrosis: Therefore, it is recommended that more extensive studies be carried out for a better understanding of the exact mechanism of hepatoprotective action of IL-22 and the development of new, better, and safer therapeutic avenues for hepatoprotection in patients of liver fibrosis, cirrhosis, and other kinds of liver disorders.